Qiu Sun
Impact in
- Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
- Epigenetics and DNA Methylation
-
- Computational Drug Discovery Methods
Papers in
-
- Melanoma and MAPK Pathways 5
- Protein Degradation and Inhibitors 5
- Cancer-related gene regulation 4
- Ubiquitin and proteasome pathways 3
- PI3K/AKT/mTOR signaling in cancer 3
-
- Synthesis and biological activity 4
- Co-authors
- Huan Xiao (7 shared papers)Burkhard König (6 shared papers)Lingling Ma (2 shared papers)Mengyuan Huang (2 shared papers)Lili Tian (1 shared paper)Guan Wang (9 shared papers)Liang Ouyang (13 shared papers)Yuquan Wei (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (6 papers)Signal Transduction and Targeted Therapy (4 papers)Journal of Medicinal Chemistry (4 papers)Acta Pharmaceutica Sinica B (3 papers)Clinical Radiology (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Qiu Sun
57 papers receiving 1.7k citations
Qiu Sun's Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 826
- Computational Theory and Mathematics 196
- Oncology 239
- Infectious Diseases 151
- Pharmacology 72
Countries citing papers authored by Qiu Sun
This map shows the geographic impact of Qiu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiu Sun more than expected).
Fields of papers citing papers by Qiu Sun
This network shows the impact of papers produced by Qiu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiu Sun. The network helps show where Qiu Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Qiu Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics Hit paper breakdown → | 2017 | 423 |
| 2 | Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance Hit paper breakdown → | 2021 | 192 |
| 3 | 2021 | 110 | |
| 4 | 2021 | 96 | |
| 5 | 2020 | 77 | |
| 6 | 2015 | 69 | |
| 7 | 2019 | 55 | |
| 8 | 2023 | 51 | |
| 9 | 2020 | 45 | |
| 10 | 2009 | 45 | |
| 11 | 2015 | 43 | |
| 12 | 2023 | 41 | |
| 13 | 2023 | 38 | |
| 14 | 2018 | 37 | |
| 15 | 2015 | 34 | |
| 16 | 2022 | 33 | |
| 17 | 2022 | 23 | |
| 18 | 2020 | 20 | |
| 19 | 2013 | 16 | |
| 20 | 2009 | 15 |
About Qiu Sun
Qiu Sun is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cardiology and Cardiovascular Medicine and Plant Science, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Protein Degradation and Inhibitors (5 papers), Cancer-related gene regulation (4 papers), Synthesis and biological activity (4 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Mechanisms and Therapy (3 papers), Peptidase Inhibition and Analysis (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). The work is most often cited by research in Molecular Biology (826 citations), Computational Theory and Mathematics (196 citations), Oncology (239 citations), Infectious Diseases (151 citations) and Pharmacology (72 citations). Qiu Sun has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Huan Xiao, Burkhard König, Lingling Ma, Mengyuan Huang, Lili Tian, Guan Wang, Liang Ouyang, Yuquan Wei, Feng Zhu and Xiaoyu Zhang. Their work appears in journals such as European Journal of Medicinal Chemistry, Signal Transduction and Targeted Therapy, Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B and Clinical Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.